Medical Developments International Ltd (MVP) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.013x

Based on the latest financial reports, Medical Developments International Ltd (MVP) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$709.00K ≈ $501.66K USD) by net assets (AU$55.10 Million ≈ $38.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medical Developments International Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Medical Developments International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medical Developments International Ltd total liabilities for a breakdown of total debt and financial obligations.

Medical Developments International Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medical Developments International Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
United Recommend International Co Ltd
TWO:5321
0.167x
Urbanise.com Ltd
AU:UBN
0.336x
Aemulus Holdings Bhd
KLSE:0181
-0.202x
Heimstaden AB Pfd.
ST:HEIM-PREF
0.009x
Hipay Group SA
PA:ALHYP
0.066x
Inchcape PLC
LSE:INCH
0.101x
OTRS AG
F:TR9
0.155x
WHA Business Complex Freehold and Leasehold Real Estate Investment Trust
BK:WHABT
0.011x

Annual Cash Flow Conversion Efficiency for Medical Developments International Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Medical Developments International Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see MVP market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$55.10 Million
≈ $38.99 Million
AU$-43.00K
≈ $-30.43K
-0.001x +99.67%
2024-06-30 AU$45.73 Million
≈ $32.36 Million
AU$-10.78 Million
≈ $-7.63 Million
-0.236x -16.20%
2023-06-30 AU$81.31 Million
≈ $57.54 Million
AU$-16.50 Million
≈ $-11.67 Million
-0.203x -8.40%
2022-06-30 AU$57.30 Million
≈ $40.54 Million
AU$-10.72 Million
≈ $-7.59 Million
-0.187x -45.11%
2021-06-30 AU$68.30 Million
≈ $48.33 Million
AU$-8.81 Million
≈ $-6.23 Million
-0.129x -3349.26%
2020-06-30 AU$43.34 Million
≈ $30.66 Million
AU$172.00K
≈ $121.70K
0.004x -99.17%
2019-06-30 AU$44.59 Million
≈ $31.55 Million
AU$21.27 Million
≈ $15.05 Million
0.477x +460.77%
2018-06-30 AU$21.04 Million
≈ $14.89 Million
AU$1.79 Million
≈ $1.27 Million
0.085x -54.19%
2017-06-30 AU$21.60 Million
≈ $15.28 Million
AU$4.01 Million
≈ $2.84 Million
0.186x -70.72%
2016-06-30 AU$19.02 Million
≈ $13.46 Million
AU$12.07 Million
≈ $8.54 Million
0.634x +228.69%
2015-06-30 AU$17.41 Million
≈ $12.32 Million
AU$3.36 Million
≈ $2.38 Million
0.193x +135.79%
2014-06-30 AU$15.82 Million
≈ $11.20 Million
AU$1.29 Million
≈ $916.30K
0.082x +31.75%
2013-06-30 AU$15.73 Million
≈ $11.13 Million
AU$977.00K
≈ $691.29K
0.062x -68.60%
2012-06-30 AU$16.17 Million
≈ $11.44 Million
AU$3.20 Million
≈ $2.26 Million
0.198x -5.67%
2011-06-30 AU$14.46 Million
≈ $10.23 Million
AU$3.03 Million
≈ $2.14 Million
0.210x +47.18%
2010-06-30 AU$12.71 Million
≈ $8.99 Million
AU$1.81 Million
≈ $1.28 Million
0.142x +31.08%
2009-06-30 AU$11.81 Million
≈ $8.36 Million
AU$1.28 Million
≈ $908.51K
0.109x +4.45%
2008-06-30 AU$11.80 Million
≈ $8.35 Million
AU$1.23 Million
≈ $868.89K
0.104x -9.48%
2007-06-30 AU$11.02 Million
≈ $7.80 Million
AU$1.27 Million
≈ $896.48K
0.115x -1.48%
2006-06-30 AU$9.87 Million
≈ $6.99 Million
AU$1.15 Million
≈ $815.11K
0.117x +72.27%
2005-06-30 AU$8.40 Million
≈ $5.94 Million
AU$569.00K
≈ $402.60K
0.068x +41.46%
2004-06-30 AU$8.37 Million
≈ $5.93 Million
AU$401.00K
≈ $283.73K
0.048x --

About Medical Developments International Ltd

AU:MVP Australia Drug Manufacturers - Specialty & Generic
Market Cap
$36.27 Million
AU$51.26 Million AUD
Market Cap Rank
#23047 Global
#890 in Australia
Share Price
AU$0.46
Change (1 day)
+0.00%
52-Week Range
AU$0.37 - AU$0.76
All Time High
AU$11.06
About

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more